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Abstract
Background: Acute post-anoxic myoclonus (PAM) can be divided into an unfavorable (generalized/subcortical) and more favorable ((multi)focal/cortical)
outcome group that could support prognostication in post-anoxic encephalopathy; however, the inter-rater variability of clinically assessing these PAM subtypes is
unknown.
Methods: We prospectively examined PAM patients using a standardized video protocol. Videos were rated by three neurologists who classified PAM phenotype
(generalized/(multi)focal), stimulus sensitivity, localization (proximal/distal/both), and severity (Clinical Global Impression-Severity Scale (CGI-S) and Unified
Myoclonus Rating Scale (UMRS)).
Results: Poor inter-rater agreement was found for phenotype and stimulus sensitivity (k5–0.05), moderate agreement for localization (k50.46). Substantial
agreement was obtained for the CGI-S (intraclass correlation coefficient (ICC)50.64) and almost perfect agreement for the UMRS (ICC50.82).
Discussion: Clinical assessment of PAM is not reproducible between physicians, and should therefore not be used for prognostication. PAM severity measured by
the UMRS appears to be reliable; however, the relation between PAM severity and outcome is unknown.
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Introduction
The presence of myoclonus in the first few days after anoxic brain
injury has traditionally been associated with an unfavorable outcome
in patients with post-anoxic encephalopathy (PAE).1,2 This acute post-
anoxic myoclonus (PAM) differs in clinical characteristics, prognosis
and treatment from the Lance–Adams syndrome, in which myoclonus
usually occurs a few weeks after the anoxic event.2
Nowadays, in the era of target temperature management, 9–14% of
these PAM patients survive.3–5 The current incidence of PAM in PAE
is estimated to be 20%.3,4 In the literature, a PAM-subtype-specific
prognosis has been reported: (multi)focal PAM had a better chance of
good functional outcome (17–18%) than PAE patients without PAM.
In contrast, patients with generalized PAM only had a favorable
outcome in 3–6%.1,4–6 This might implicate that the PAM subtype can
be supportive in PAE prognostication.7–9
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(Multi)focal PAM consists of subtle asynchronous jerks involving
the distal musculature and is considered to have a cortical origin.4,10
Stimulus sensitivity is more often present in the cortical than the
subcortical myoclonus.10 Generalized PAM (also referred to as status
myoclonus, myoclonus status epilepticus, or reticular reflex myoclonus)
is characterized by generalized synchronous jerks with preferential
involvement of proximal musculature, and is considered to have a
subcortical origin.4,6,10 Despite these well-defined differences, the
reliability of clinically differentiating between these PAM subtypes is
unknown. We investigated this in the current study.
Methods
Patients
We prospectively included 10 PAM patients from the intensive care
units of the University Medical Center Groningen, and the Lausanne
University Hospital. The institutional review board of both hospitals
approved the study. For all patients informed consent was obtained
from a legal representative. Exclusion criteria were age ,18 years,
PAM onset .72 hours, GCS (Glasgow Coma Scale) .8, history of
myoclonus, traumatic brain injury, epilepsy, possible explanation
myoclonus other than PAE, and medication overdose.
Study procedures
A standardized high-definition video protocol for examination of
PAM was conducted after first appearance of PAM. The video
protocol consisted of recording 60 seconds of rest, 30 seconds of close-
up recording of the face, and recording 32 lateralized and non-
lateralized stimuli: pain stimulus of the orbit, trapezius muscle and nail
bed; pin prick of the cheek, forearm, and foot; pupillary light response;
corneal and glabellar reflex, biceps and knee tendon reflexes; light
touch of the hand and foot; flick of the finger and toe; visual and
auditory threat; jaw and nose tapping. The video protocol is available
as supplementary material (Supplement A), and an example examina-
tion is provided in Video 1.
Videos were rated by three experienced (intensive-care) neurologists
(B.M.J., J.N., J.H.) blinded for outcome. Raters classified PAM phe-
notype (generalized or (multi)focal), localization (proximal, distal, or
both), stimulus sensitivity (present or absent), severity (Clinical Global
Impression of Severity Scale (CGI-S); range 1–7), and the ‘‘myoclonus
at rest’’ part of the Unified Myoclonus Rating Scale (UMRS) score
(range 0–128).11,12 Additionally, all stimuli were scored separately regard-
ing stimulus sensitivity. If raters considered an item as not evaluable it was
excluded from further analysis. The evaluations of PAM patients (total
3610530 evaluations) were ordered based on the total number of
stimulus-sensitive stimuli (0, 1–2, 3–4, 5–6, 7–8, 9–10). These categories
were corrected for group size, and correlated with how often a rater
concluded ‘‘stimulus-sensitive PAM’’. Finally, painful stimuli (pain stimulus
of orbit, trapezius muscle, nail bed, and pin prick) were compared with
non-painful stimuli in evoking PAM.
Statistical analysis
Inter-rater variability was calculated by the intraclass correlation
coefficient (ICC) and kappa (Fleiss) statistics.13 The two-way mixed model
and single measurement coefficients of ICCs were used. According to
Landis and Koch,14 we interpreted kappa and ICC outcomes as follows:
,0.005poor; 0.00–0.205slight; 0.21–0.405fair; 0.41–0.605moderate;
0.61–0.805substantial; .0.815almost perfect. The correlation between
the amount of stimulus-sensitive stimuli and the conclusion ‘‘stimulus
sensitive PAM’’ was performed using Spearman’s correlation. Stimulus
sensitivity of PAM after painful and non-painful stimuli was compared
using a two-sided Fisher’s exact test. p-Values of ,0.05 were considered
as statistically significant.
Results
Patients had a mean age of 59 (SD¡16) years, and seven were male
(Detailed patient characteristics are provided in Table 1). All patients
were treated with target temperature management. One patient had a
good recovery with only mild cognitive deficits after 6 months (Case 2
in Table 2, Video 1). All other patients died in the acute setting.
Patients were examined a mean of 9 hours (range 2–24 hours) after the
first appearance of PAM. In seven patients no symptomatic treatment
was given at the moment of examination.
Inter-rater variability
Poor agreement was found among raters in assessing PAM
phenotype (generalized or (multi)focal) (k5–0.05, 95% confidence
interval (CI) –0.40 to 0.31). Agreement for the localization of PAM
(proximal, distal, or both) was moderate (k50.46, 95% CI 0.20–0.73).
In the rating scales used to assess PAM severity, substantial agreement
was obtained for the CGI-S (ICC 0.64, 95% CI 0.14–0.89) and almost
perfect agreement for the UMRS (ICC 0.82, 95% CI 0.57–0.95)
(Figure 1). The specific scores of the raters are provided in Table 2.
Stimulus sensitivity
In total 294 of 320 (92%) stimuli were examined by the raters. Poor
agreement was found for confirming the presence or absence of
Video 1. Example Examination of a Post-anoxic Myoclonus Patient.
The (abridged) systematic examination of post-anoxic myoclonus (PAM) Case 2
(Table 2) and the video protocol of this study (Supplement A). Case 2 displays
slight myoclonus in rest, but it seems to increase in frequency and severity after
the application of stimuli. This patient is the only PAM case of this cohort that
survived and recovered with only mild cognitive deficits after 6 months.
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Table 1. Clinical Characteristics
Age, years, mean (SD) 59 (16)
Male, n 7
Initial rhythm, n
Shockable (VF/VT) 3
Non-shockable (bradycardia/asystole/PEA) 7
Primary cause of CPR, n (%)
Cardiac 3
Hypoxic 6
Unknown 1
Location of arrest, n
OHCA 8
IHCA 2
Time to ROSC (minutes), median (IQR) 18 (10–23)
Time to occurrence of PAM (hours), median (IQR) 14 (10–36)
Initial treatment of PAM, n
Propofol 8
Clonazepam 3
Sodium valproate 3
Levetiracetam 2
Other benzodiazepine 2
.1 drug 4
SEP N20, n
Present 5
Bilaterally absent 5
EEG result, n
Normal/mild encephalopathic 0
Diffuse slowing 1
Status epilepticus 4
Burst suppression 4
Low voltage/isoelectric 0
No EEG 1
Outcome, n
Recovery with mild cerebral disability 1
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‘‘stimulus-sensitive PAM’’ in a patient (k5–0.05, 95% CI –0.40 to
0.30) (Figure 1, Table 2). Likewise, when raters examined all 294
stimuli regarding the effect on PAM, fair agreement was found
(k50.276, 95% CI 0.21–0.34). A positive correlation was present
between the conclusion ‘‘stimulus-sensitive PAM’’ and the amount of
stimuli rated positive (r50.75, p,0.001). Finally, painful stimuli were
significantly more likely (p,0.001) to evoke PAM than non-painful
stimuli (respectively 21% and 7%).
Discussion
Our results suggest that the clinical assessment of myoclonus in
the first few days after anoxic brain injury is not consistent between
different raters. Since phenotype, localization, and stimulus sensitiv-
ity findings of PAM varied considerably between raters the potential
to accurately determine the etiology, i.e. cortical versus subcortical,
was poor. We therefore conclude that clinical assessment of PAM
Table 1. Continued
Death 9
Treatment withdrawal, n 9
Time to treatment withdrawal (hours), median (IQR) 48 (38–130)
Reason for treatment withdrawal, n
Neurological examination 4
SEP 5
EEG 5
Combination 3
Abbreviations: CPR, Cardiopulmonary Resuscitation; EEG, Electroencephalography; ICU, Intensive Care Unit; IHCA, In Hospital Cardiac
Arrest; IQR, Interquartile Range; OHCA, Out of Hospital Cardiac Arrest; PAM, Post-anoxic Myoclonus; PEA, Pulseless Electrical Activity;
ROSC, Return of Spontaneous Circulation; SD, Standard Deviation; SEP, Somatosensory Evoked Potential; VF, Ventricular Fibrillation;
VT, Ventricular Tachycardia.
Table 2. Video Assessment Scores of Post-anoxic Myoclonus
PAM Phenotype Stimulus Sensitivity Localization CGI–S UMRS
Case R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3
1 gz mf mf – – – p+d p+d p+d 6 5 4 29 35 18
2 mf gz mf + – + p p p 4 4 2 4 8 2
3 gz gz gz + – – p+d p+d p+d 7 7 5 87 52 74
4 gz mf mf – – – p+d p+d d 4 4 3 22 8 32
5 mf mf mf + – – d d d 2 3 2 1 4 2
6 mf mf mf + – – p p+d p 2 2 2 4 6 5
7 gz mf mf + – + p+d p+d p+d 5 4 2 14 19 18
8 gz mf mf + – + p+d p+d p+d 6 6 4 64 41 76
9 gz mf mf – – – d p+d p+d 6 4 4 33 23 27
10 gz mf mf + – – p p+d d 5 5 4 34 22 59
Abbreviations: +, stimulus sensitivity present; –, stimulus sensitivity absent; CGI-S, Clinical Global Impression of Severity Scale; d, Distal;
gz, Generalized; mf, (Multi)focal; p, Proximal; PAM, Post-anoxic Myoclonus; R, Rater; UMRS, Unified Myoclonus Rating Scale.
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should not be used for PAE prognostication or guiding treatment
decisions. This is in line with the current European recommenda-
tions, which do not include PAM as a single outcome predictor for
PAE.8
The clinical phenotype of PAM appears to be a continuum ranging
from severe generalized PAM on one side of the spectrum and subtle
focal PAM on the other side. Most likely, the PAM patients on one end
of the spectrum can be assessed reliably, but as most cases show jerks
in the middle of the spectrum clinical assessment is complicated and
not interpreted consistently between raters.4,5 Other factors that are
known to complicate the clinical evaluation of PAM are the dynamic
character and cyclicality, sporadic nature, stimulus dependency, use
of sedatives or neuromuscular blockers, and the presence of other
involuntary movements.8,15 In our study, these factors could have
caused the differences in interpretation, but we were unable to inves-
tigate this because of the small sample size. Future studies towards the
etiology of PAM should use electroencephalography–electromyography
to determine the origin of the myoclonus. Electrophysiology might prove
a better tool to discriminate between cortical and subcortical myoclonus
and a possible tool to use for prognosis.10
The CGI-S scale and especially the UMRS appear to represent
reliable assessments of PAM severity. The relation between PAM
severity and outcome is however unknown. The CGI-S and UMRS
are recognized as reliable scales, but have not previously been used
for PAM in particular.11,12 Moreover, in research evaluating the
treatment of PAM, the UMRS could be reliably used to assess
intervention effects.
An additional finding of our study was that painful stimuli induced
significantly more PAM than non-painful stimuli. Since painful stimuli
activate the ascending arousal system (AAS),16 subcortical structures
could be triggered. Alternatively, since AAS promotes cortical excit-
ability,16 (cortical) PAM might occur.
A potential limitation of our study was that assessments were based on
video recordings leading to an observation that is less vivid. Contrarily,
video recordings ensure that raters have the same information and the use
of video is well established in movement disorders. Furthermore, the use
of video enables the raters to assess myoclonus multiple times and to look
at different parts of the video at different moments. Another limitation
was the relatively small number of patients included.
In conclusion, our study shows that the clinical assessment of acute
PAM is not consistent between physicians, and therefore the use of
PAM for prognostication or guiding treatment decisions in PAE should
be restrained. PAM severity measured by the UMRS appears to be
reliable; however, the relation between PAM severity and outcome has
not yet been established.
Supplementary Material
Supplement A referenced in this article is available here: https://
doi.org/10.7916/D85T3XQK.
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